Management of epidemiological research in a particular region (based on ESSE-RF2 in the Ryazan region)
https://doi.org/10.15829/1560-4071-2019-6-131-134
Abstract
Despite the decline in cardiovascular mortality in Russia over the past 15 years, it remains relevant to study the possibilities of its further reducing. And preventive measures of risk factors reducing play the main role. However, before developing preventive measures, it is necessary to study the prevalence and structure of risk factors in a particular region, since Russia is a huge country and each region is different from another. The study of this issue needs large-scale epidemiological studies, the conduct of which is very difficult in organizational terms. This article presents our own experience in successfully organizing a regional phase of epidemiological research.
About the Authors
N. V. DobryninaRussian Federation
Ryazan.
ResearcherID: U-9725-2018
Competing Interests: Nothing to declare
K. A. Moseychuk
Russian Federation
Ryazan.
ResearcherID: I-2294-2018
Competing Interests: Nothing to declare
N. N. Nikulina
Russian Federation
Ryazan.
ResearcherID: A-8594-2017
Competing Interests: Nothing to declare
K. G. Pereverzeva
Russian Federation
Ryazan.
ResearcherID: I-3658-2018
Competing Interests: Nothing to declare
E. V. Filippov
Russian Federation
Ryazan.
ResearcherID: О-1490-2016
Competing Interests: Nothing to declare
References
1. Boytsov SA, Deev AD, Shalnova SA. Mortality from cardiovascular diseases in the Russian Federation and possible mechanisms of it. Journal of neurology and psychiatry. 2018;8:98-103. (In Russ.) doi:10.17116/jnevro201811808198.
2. Boytsov SA, Deev AD, Shalnova SA. Mortality and risk factors for non-communicable diseases in Russia: Specific features, trends, and prognosis. Terapevticheskii arkhiv. 2017;1 (89):5-13. (In Russ.) doi:10.17116/terarkh20178915-13.
3. Research organizing committee of the ESSE-RF project. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study. Preventive medicine. 2013;6:25-34. (In Russ.)
4. Dawber TR, Moore FE, Mann GV. Coronary heart disease in the Framingham study. Am J Public Health Nations Health. 1957;47:4-24.
5. Kannel WB, Dawber TR, Cohen ME, McNamara PM. Vascular Disease of the Brain-Epidemiologic Aspects: the Farmingham Study. Am J Public Health Nations Health. 1965;55:1355-66.
6. Yusuf S, Hawken S, Ounpuu S, et al.; INTERHEART Study Investigators. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364 (9438):937-52.
7. Bandosz P, O'Flaherty M, Drygas W, et al. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modeling study. BMJ. 2012;344:1-10.
8. Roger VL, Go AS, Lloyd-Jones DM, et al.; American Heart Association Statistics Committee and Stroke StatisticsSubcommittee. Heart Disease and Stroke Statistics — 2012 Update: a reportfrom the American Heart Association. Circulation. 2012;125 (1):2-220.
9. Yakushin SS, Shal'nova SA, Potemkina RA, et al. Experience in organizing an epidemiological study of risk factors for noncommunicable diseases in the Ryazan Region: results of the pilot MERIDIAN-RO project. Profilakticheskaya meditsina. 2012; (6):20-4. (In Russ.)
10. Приказ Минздрава России от 01 апреля 2016 № 200-н “Об утверждении правил надлежащей клинической практике” [удаленный доступ: http://www/roszdravnadzor.ru].
11. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [удаленный доступ: http://www.wma.net/en/30publications/10policies/b3/17c.pdf].
12. Федеральный закон Российской Федерации от 27 июля 2006 г. № 152-ФЗ “О персональных данных” [удаленный доступ: http://www.rg.ru/2006/07/29/personaljnye-dannye-dok.html].
13. Kish L. Survey Sampling. New York: John Wiley and Sons 1965.
14. Balanova YuA, Imaeva AE, Yakushin SS, et al. Epidemiological surveys: difficulties and achievements. Participating regions share their experience Profilakticheskaya meditsina. 2017; (5):65-73. (In Russ.) doi:10.17116/profmed201720565-73.
Review
For citations:
Dobrynina N.V., Moseychuk K.A., Nikulina N.N., Pereverzeva K.G., Filippov E.V. Management of epidemiological research in a particular region (based on ESSE-RF2 in the Ryazan region). Russian Journal of Cardiology. 2019;(6):131-134. (In Russ.) https://doi.org/10.15829/1560-4071-2019-6-131-134